271 related articles for article (PubMed ID: 32354090)
1. Dry Eye Disease and Tear Cytokine Levels-A Meta-Analysis.
Roda M; Corazza I; Bacchi Reggiani ML; Pellegrini M; Taroni L; Giannaccare G; Versura P
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354090
[TBL] [Abstract][Full Text] [Related]
2. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.
Na KS; Mok JW; Kim JY; Rho CR; Joo CK
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923
[TBL] [Abstract][Full Text] [Related]
3. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
[TBL] [Abstract][Full Text] [Related]
4. Association of Tear Cytokine Ratios with Symptoms and Signs of Dry Eye Disease: Biomarker Data from the Dry Eye Assessment and Management Study.
Zhao CS; Chen Y; Ying GS; Asbell PA;
Curr Eye Res; 2024 Jan; 49(1):16-24. PubMed ID: 37781912
[TBL] [Abstract][Full Text] [Related]
5. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease.
Enríquez-de-Salamanca A; Castellanos E; Stern ME; Fernández I; Carreño E; García-Vázquez C; Herreras JM; Calonge M
Mol Vis; 2010 May; 16():862-73. PubMed ID: 20508732
[TBL] [Abstract][Full Text] [Related]
6. Tear biomarkers in dry eye disease: Progress in the last decade.
Kumar NR; Praveen M; Narasimhan R; Khamar P; D'Souza S; Sinha-Roy A; Sethu S; Shetty R; Ghosh A
Indian J Ophthalmol; 2023 Apr; 71(4):1190-1202. PubMed ID: 37026250
[TBL] [Abstract][Full Text] [Related]
7. Association of Tear Cytokine Concentrations with Symptoms and Signs of Dry Eye Disease: Baseline Data from the Dry Eye Assessment and Management (DREAM) Study.
Roy NS; Wei Y; Ying GS; Maguire MG; Asbell PA;
Curr Eye Res; 2023 Apr; 48(4):339-347. PubMed ID: 36632643
[TBL] [Abstract][Full Text] [Related]
8. Tear Luminex Analysis in Dry Eye Patients.
Zhao H; Li Q; Ye M; Yu J
Med Sci Monit; 2018 Oct; 24():7595-7602. PubMed ID: 30356032
[TBL] [Abstract][Full Text] [Related]
9. Tear Interferon-Gamma as a Biomarker for Evaporative Dry Eye Disease.
Jackson DC; Zeng W; Wong CY; Mifsud EJ; Williamson NA; Ang CS; Vingrys AJ; Downie LE
Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4824-4830. PubMed ID: 27654409
[TBL] [Abstract][Full Text] [Related]
10. A latent profile analysis of tear cytokines and their association with severity of dry eye disease in the Dry Eye Assessment and Management (DREAM) study.
Chen Y; Mallem K; Asbell PA; Ying GS
Sci Rep; 2024 Jan; 14(1):526. PubMed ID: 38177232
[TBL] [Abstract][Full Text] [Related]
11. sPLA
Wei Y; Asbell PA
Exp Eye Res; 2020 Dec; 201():108209. PubMed ID: 33011237
[TBL] [Abstract][Full Text] [Related]
12. A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection.
Agrawal R; Balne PK; Veerappan A; Au VB; Lee B; Loo E; Ghosh A; Tong L; Teoh SC; Connolly J; Tan P
Cytokine; 2016 Dec; 88():77-84. PubMed ID: 27585367
[TBL] [Abstract][Full Text] [Related]
13. Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial.
Pinto-Fraga J; Enríquez-de-Salamanca A; Calonge M; González-García MJ; López-Miguel A; López-de la Rosa A; García-Vázquez C; Calder V; Stern ME; Fernández I
Ocul Surf; 2018 Jul; 16(3):368-376. PubMed ID: 29772277
[TBL] [Abstract][Full Text] [Related]
14. The Use of Conjunctival Staining to Measure Ocular Surface Inflammation in Patients With Dry Eye.
Yang S; Lee HJ; Kim DY; Shin S; Barabino S; Chung SH
Cornea; 2019 Jun; 38(6):698-705. PubMed ID: 30844839
[TBL] [Abstract][Full Text] [Related]
15. Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures.
Wei Y; Gadaria-Rathod N; Epstein S; Asbell P
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8327-36. PubMed ID: 24204044
[TBL] [Abstract][Full Text] [Related]
16. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
Lu R; Huang R; Li K; Zhang X; Yang H; Quan Y; Li Q
Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model.
Cocho L; Fernández I; Calonge M; Martínez V; González-García MJ; Caballero D; López-Corral L; García-Vázquez C; Vázquez L; Stern ME; Enríquez-de-Salamanca A
Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):746-58. PubMed ID: 26927568
[TBL] [Abstract][Full Text] [Related]
18. Tear Proteomics Study of Dry Eye Disease: Which Eye Do You Adopt as the Representative Eye for the Study?
Kuo MT; Fang PC; Kuo SF; Chen A; Huang YT
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401599
[TBL] [Abstract][Full Text] [Related]
19. Conjunctival cytokine expression in symptomatic moderate dry eye subjects.
Narayanan S; Miller WL; McDermott AM
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2445-50. PubMed ID: 16723455
[TBL] [Abstract][Full Text] [Related]
20. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]